Procedure-Specific Thromboprophylaxis in Urological Surgeries: A Narrative Review
Urology Journal,
Vol. 20 (2023),
25 December 2022
,
Page 8068
https://doi.org/10.22037/uj.v20i.8068
Abstract
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a serious complication that can occur after urological surgeries. It is a leading cause of preventable hospital-related morbidity and mortality in surgical patients [1]. In urological surgeries, VTE remains a serious complication and a significant challenge [2] and PE is considered as the most common cause of postoperative death in patients undergoing major urologic surgery [3]. The decision to use thromboprophylaxis in urological surgeries involves weighing the reduction in VTE risk against the potential increase in perioperative bleeding [4]. However, there is a lack of procedure-specific evidences about thromboprophylaxis in urologic surgeries. Therefore, we have reviewed the available evidence on thromboprophylaxis in urological surgeries and we have tried to summarized these evidences in a procedure specific context.
- Surgery; Review
How to Cite
References
Nisio M, Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet 2016;388(10063):3060-3073.
Tikkinen KA, Agarwal A, Craigie S, et al. Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev 2014;3:150.
Rice KR, Brassell SA, McLeod DG. Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Reviews in urology. 2010;12(2-3):e111.
Violette PD, Cartwright R, Briel M, Tikkinen KA, Guyatt GH. Guideline of guidelines: thromboprophylaxis for urological surgery. BJU international. 2016 Sep;118(3):351-8.
Yhim HY, Jang MJ, Bang SM, Kim KH, Kim YK, Nam SH, Bae SH, Kim SH, Mun YC, Kim I, Jung CW. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. Journal of thrombosis and haemostasis. 2014 Jul 1;12(7):1035-43.
Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006; 243: 89–95.
Rice KR, Brassell SA, McLeod DG. Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev. Urol. 2010; 12: e111–24.
Tikkinen KA, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RA, Ali B, Eryuzlu L, Geraci J. Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis. European urology. 2018 Feb 1;73(2):242-51.
Tikkinen KA, Craigie S, Agarwal A, Siemieniuk RA, Cartwright R, Violette PD, Novara G, Naspro R, Agbassi C, Ali B, Imam M. Procedure-specific risks of thrombosis and bleeding in urological non-cancer surgery: systematic review and meta-analysis. European urology. 2018 Feb 1;73(2):236-41.
Cano Garcia C, Tappero S, Piccinelli ML, Barletta F, Incesu RB, Morra S, Scheipner L, Baudo A, Tian Z, Hoeh B, Chierigo F. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery. Annals of Surgical Oncology. 2023 Sep 18:1-0.
Saluja M, Gilling P. Venous thromboembolism prophylaxis in urology: A review. International Journal of Urology. 2017 Aug;24(8):589-93.
Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, Fallarino A, Corso C, Valeriani E, Menichelli D, Pignatelli P. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. International Journal of Molecular Sciences. 2023 Feb 5;24(4):3169.
Irmak B, KARADAĞ M, Emre NY. The risk factors for preoperative and postoperative deep vein thrombosis in surgical patients. Clinical and Experimental Health Sciences. 2022 Mar 3;12(1):120-7.
Li M, Guo Q, Hu W. Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: a systematic review and meta-analysis. Thrombosis research. 2019 Jan 1;173:48-56.
Cronin M, Dengler N, Krauss ES, Segal A, Wei N, Daly M, Mota F, Caprini JA. Completion of the Updated Caprini Risk Assessment Model (2013 Version). Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619838052.
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010 Nov;8(11):2450-7.
Chopard P,Spirk D, Bounameaux H. Identifying acutely ill medical patients requiring thrombophylaxis.J thrombosis Haemost.2006;4(4):915-16.
Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA Jr; IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007 Sep;132(3):936-45.
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008, 111 (10): 4902-907.
Chopra V, Kaatz S, Conlon A, Paje D, Grant PJ, Rogers MAM, Bernstein SJ, Saint S, Flanders SA. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost. 2017 Oct;15(10):1951-1962.
Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, Spyropoulos AC, Merli GJ, Zotz RB, Bergmann JF, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA, Fitzgerald G, Anderson FA Jr; IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007 Sep;132(3):936-45.
Golemi I, Salazar Adum JP, Tafur A, et al. Venous thromboembolism prophylaxis using the Caprini score. Dis Mon 2019;65:249-98.
Nam JH, Kim DH, Yoo JH, Hwang JH, Chang JD. Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?—Retrospective casecontrol study. PLoS One. 2017;12(11):e0187337.
Kakkos S, Kirkilesis G, Caprini JA, Geroulakos G, Nicolaides A, Stansby G, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database of Systematic Reviews. 2022(1).
Morris RJ, Woodcock JP. Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis?: A systematic review of direct clinical comparisons. Annals of surgery. 2010 Mar 1;251(3):393-6.
Sachdeva A, Dalton M, Amaragiri SV, Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2014;12:CD001484.
Speth J. Guidelines in Practice: Prevention of Venous Thromboembolism. AORN journal. 2023 Nov;118(5):321-8.
Mahdy EW, Abd El-Hamid AM, Shady RM, Aglan BM. Choosing Between Enoxaparin and Fondaparinux for the Prevention of Thromboembolism: A Meta-Analysis of Randomized Trials. Egyptian Journal of Critical Care Medicine. 2022 Mar 1;9(1):22-30.
Jeffery PC, Nicolaides AN. Graduated compression stockings in the prevention of postoperative deep vein thrombosis. British Journal of Surgery. 1990 Apr;77(4):380-3.
Weinberger J, Cipolle M. Mechanical prophylaxis for post-traumatic VTE: stockings and pumps. Current trauma reports. 2016 Mar;2(1):35-41.
Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Annals of surgery. 2004 Feb;239(2):162.
Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT open reviews. 2018 Apr 27;3(4):136-48.
Diep R, Garcia D. Does aspirin prevent venous thromboembolism?. Hematology 2014, the American Society of Hematology Education Program Book. 2020 Dec 4;2020(1):634-41.
Forrest JB, Clemens JQ, Finamore P, Leveillee R, Lippert M, Pisters L, Touijer K, Whitmore K. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. The Journal of urology. 2009 Mar;181(3):1170-7.
Bauer KA, Hawkins DW, Peters PC, Petitou M, Herbert JM, van Boeckel CA, Meuleman DG. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents—the selective factor Xa inhibitors. Cardiovascular drug reviews. 2002 Mar;20(1):37-52.
Mahdy EW, Abd El-Hamid AM, Shady RM, Aglan BM. Choosing Between Enoxaparin and Fondaparinux for the Prevention of Thromboembolism: A Meta-Analysis of Randomized Trials. Egyptian Journal of Critical Care Medicine. 2022 Mar 1;9(1):22-30.
Bauer KA, Eriksson BI, Lassen MR, et al. Fondaparinux compared with Enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001;345(18):1305–1310.
Michael RL, Bauer KA, Eriksson BI, Turpie AGG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip replacement surgery: A randomized double-blind comparison. Lancet 2002;359:1715–1720.
Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, Sasaki H, Miki J, Yamada H, Furuta A, Miki K. Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial. International Journal of Urology. 2016 Nov;23(11):923-8.
https://emedicine.medscape.com/article/1267714-medication?form=fpf#1
Tikkinen KA, Cartwright R, Gould MK, Naspro R, Novara G, Sandset PM, Violette PD, Guyatt GH. Thromboprophylaxis in urological surgery. EAU Guidelines Office. 2017.
Shakiba B, Kabir A, Irani S, Torabi N, Nourmohamad V, Farid M. Evaluation of the quality of clinical guidelines for prophylaxis of venous thromboembolism in urological surgeries by the AGREE II review instrument. Health Science Reports. 2023 Feb;6(2):e1118.
Clément C, Rossi P, Aissi K, Barthelemy P, Guibert N, Auquier P, et al. Incidence, Risk Profile and Morphological Pattern of Lower Extremity Venous Thromboembolism After Urological Cancer Surgery. Journal of Urology 2011;186:2293–7. https://doi.org/10.1016/j.juro.2011.07.074.
Schiffmann J, Gandaglia G, Larcher A, Sun M, Tian Z, Shariat SF, et al. Contemporary 90-day mortality rates after radical cystectomy in the elderly. European Journal of Surgical Oncology (EJSO) 2014;40:1738–45. https://doi.org/10.1016/j.ejso.2014.10.004.
Elsayed AS, Ozair S, Iqbal U, Mostowy M, Jing Z, Gibson S, et al. Prevalence and Predictors of Venous Thromboembolism After Robot-Assisted Radical Cystectomy. Urology 2021;149:146–53. https://doi.org/10.1016/j.urology.2020.11.014.
Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, et al. Temporal trends in venous thromboembolism after radical cystectomy. Urologic Oncology: Seminars and Original Investigations 2018;36:361.e15-361.e21. https://doi.org/10.1016/j.urolonc.2018.05.015.
Brennan K, Karim S, Doiron RC, Siemens DR, Booth CM. Venous Thromboembolism and Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study. Bladder Cancer 2018;4:419–28. https://doi.org/10.3233/BLC-180184.
Rich JM, Elkun Y, Geduldig J, Lavallee E, Mehrazin R, Attalla K, et al. Outcomes from a prospectively implemented protocol using apixaban after robot‐assisted radical cystectomy. BJU Int 2023;132:390–6. https://doi.org/10.1111/bju.16036.
Pariser JJ, Pearce SM, Anderson BB, Packiam VT, Prachand VN, Smith ND, et al. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin. Journal of Urology 2017;197:302–7. https://doi.org/10.1016/j.juro.2016.08.090.
Chiang HA, Cheng PJ, Speed JM, Steinberg J, Najjar PA, Steele GS, et al. Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol. Eur Urol Focus 2020;6:74–80. https://doi.org/10.1016/j.euf.2018.08.025.
Chen EC, Papa N, Lawrentschuk N, Bolton D, Sengupta S. Incidence and risk factors of venous thromboembolism after pelvic uro‐oncologic surgery – a single center experience. BJU Int 2016;117:50–3. https://doi.org/10.1111/bju.13238.
Naik R, Mandal I, Hampson A, Lane T, Adshead J, Rai BP, et al. The role of extended venous thromboembolism prophylaxis for major urological cancer operations. BJU Int 2019;124:935–44. https://doi.org/10.1111/bju.14906.
Cindolo L, Salzano L, Mirone V, Imbimbo C, Longo N, Kakkos SK, et al. Thromboprophylaxis in Radical Retropubic Prostatectomy: Efficacy and Patient Compliance of a Dual Modality. Urol Int 2009;83:12–8. https://doi.org/10.1159/000224861.
Säily VMJ, Pétas A, Joutsi-Korhonen L, Taari K, Lassila R, Rannikko AS. Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: Retrospective analysis of safety profile and effect on blood coagulation. Scand J Urol 2014;48:153–9. https://doi.org/10.3109/21681805.2013.817482.
Klaassen Z, Wallis CJ, Lavallée LT, Violette PD. Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World Journal of Urology. 2020 Mar;38:593-600.
Rice KR, Brassell SA, McLeod DG. Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol 2010;12:e111-24.
Naik R, Mandal I, Hampson A, Lane T, Adshead J, Rai BP, et al. The role of extended venous thromboembolism prophylaxis for major urological cancer operations. BJU Int 2019;124:935–44.
McAlpine K, Breau RH, Mallick R, Cnossen S, Cagiannos I, Morash C, et al. Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology. Urologic Oncology: Seminars and Original Investigations 2017;35:457.e1-457.e8. https://doi.org/10.1016/j.urolonc.2017.01.015.
Zeng H, Gao M, Chen J, Cui Y, Huang F, Zeng F, et al. Incidence and risk factors of venous thromboembolism after percutaneous nephrolithotomy: a single-center experience. World J Urol 2021;39:3571–7.
Bourdoumis A, Stasinou T, Kachrilas S, Papatsoris AG, Buchholz N, Masood J. Thromboprophylaxis and bleeding diathesis in minimally invasive stone surgery. Nat Rev Urol 2014;11:51–8. https://doi.org/10.1038/nrurol.2013.278.
Vandendris M, Kutnowski M, Futeral B, Gianakopoulos X, Kraytman M, Gregoir W. Prevention of post-operative deep-vein thrombosis by low-dose heparin in open prostatectomy. Urol Res 1980;8. https://doi.org/10.1007/BF00256997.
Hendolin H, Mattila MA, Poikolainen E. The effect of lumbar epidural analgesia on the development of deep vein thrombosis of the legs after open prostatectomy. Acta Chir Scand 1981;147:425–9.
Bergqvist D. Venous Thromboembolism After Surgery for Benign Prostatic Hyperplasia. World J Surg 2011;35:1824–8. https://doi.org/10.1007/s00268-011-1150-3.
Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019;3:3898–944.
- Abstract Viewed: 215 times
- Just Accepted-8068 Downloaded: 135 times